Distek Awarded U.S. Patent 8,903,673
News Feb 24, 2015
Distek, Inc. has been awarded U.S. Patent 8,903,673 for their modularity design and the individual position software control.
Distek’s patented, self-contained, modularity design is configurable for up to 8 positions when in use on the symphony 7100 “Bathless” Dissolution Instrument and 6 positions when in use on thesensIR 3200 “Bathless” Disintegrator. This modularity design allows users unprecedented ease and scalability.
“Distek is excited to have been awarded this patent which exemplifies our commitment to providing technically innovative products offering valuable feature benefits to our customer base,” says Jeff Brinker, President, Distek, Inc.
Brinker continued, “This patent in particular allows our customers a great deal of flexibility in the symphony 7100 and sensIR 3200 platforms in its modularity both mechanically as well as in the user interface design.”
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019